FitLife Brands, Inc. provides nutritional supplements and wellness products for health-conscious consumers in the United States and internationally. The company provides weight loss, sports nutrition, and general health products; general wellness products with an emphasis on natural, vegan, and organic ingredients; male health and weight loss products; energy products; general health supplements; and natural skincare and beauty products; supplements focused on targeted nutrition; supplements for weight loss, cleansing and sexual health, and total body wellness. It markets its products under the brand names of NDS Nutrition, PMD Sports, SirenLabs, CoreActive, Nutrology, Metis Nutrition, iSatori, BioGenetic Laboratories, Energize, Dr. Tobias, All-Natural Advice, Maritime Naturals, MusclePharm, Irwin Naturals, Applied Nutrition, and Nature's Secret through franchised stores, as well as through retail locations, which include specialty, mass, and online, and e-commerce platform. The company was formerly known as Bond Laboratories, Inc. and changed its name to FitLife Brands, Inc. in September 2013. FitLife Brands, Inc. was incorporated in 2005 and is headquartered in Omaha, Nebraska.
5-year financial trends. Figures in USD millions.
Latest fiscal year: 2025
Year-by-year revenue, profitability, and cash flow (USD millions, last 10 years)
| Year | Revenue | EBITDA | Net Profit | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|
| 2025 | $81M | $11M | $6M | $7M | 14.5% | 26.4% | -29.6% |
| 2024 | $64M | $13M | $9M | $10M | 24.9% | 22.3% | 69.6% |
| 2023 | $53M | $8M | $5M | $4M | 19.6% | 83.0% | 19.6% |
| 2022 | $29M | $6M | $4M | $4M | 20.7% | - | - |
Income statement, balance sheet, and cash flow as reported
Consolidated Figures in USD Millions.
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total Revenue | 28.80 | 52.70 | 64.47 | 81.46 |
| Cost Of Revenue | 16.77 | 31.27 | 36.39 | 50.01 |
| Gross Profit | 12.03 | 21.43 | 28.08 | 31.45 |
| Operating Expense | 6.08 | 12.26 | 14.71 | 19.32 |
| Operating Income | 5.96 | 9.18 | 13.37 | 12.14 |
| EBITDA | 5.89 | 8.12 | 13.35 | 10.51 |
| EBIT | 5.82 | 8.03 | 13.24 | 10.09 |
| Pretax Income | 5.82 | 7 | 11.87 | 8.23 |
| Tax Provision | 1.39 | 1.71 | 2.89 | 1.90 |
| Net Income | 4.43 | 5.30 | 8.98 | 6.33 |
| Net Income Common Stockholders | 4.43 | 5.30 | 8.98 | 6.33 |
| Total Expenses | 22.84 | 43.52 | 51.09 | 69.32 |
| Interest Expense | 0 | 1.02 | 1.37 | 1.86 |
| Interest Income | 0.12 | 0.29 | 0.07 | 0.10 |
| Selling General And Administration | 6.01 | 12.16 | 14.60 | 18.90 |
| Normalized EBITDA | 6.14 | 9.56 | 13.55 | 12.61 |
| Normalized Income | 4.62 | 6.38 | 9.14 | 7.94 |
| Basic EPS | 0.48 | 0.59 | 0.98 | 0 |
| Diluted EPS | 0.45 | 0.54 | 0.91 | 0 |
| Tax Effect Of Unusual Items | -0.06 | -0.35 | -0.05 | -0.48 |
| Tax Rate For Calcs | 0.24 | 0.24 | 0.24 | 0.23 |
| Total Unusual Items | -0.26 | -1.44 | -0.20 | -2.09 |
| Total Unusual Items Excluding Goodwill | -0.26 | -1.44 | -0.20 | -2.09 |
| Net Income From Continuing Operation Net Minority Interest | 4.43 | 5.30 | 8.98 | 6.33 |
| Reconciled Depreciation | 0.07 | 0.09 | 0.11 | 0.42 |
| Reconciled Cost Of Revenue | 16.77 | 31.27 | 36.39 | 50.01 |
| Net Interest Income | 0.12 | -0.74 | -1.30 | -1.76 |
| Net Income From Continuing And Discontinued Operation | 4.43 | 5.30 | 8.98 | 6.33 |
| Total Operating Income As Reported | 5.70 | 7.55 | 13.12 | 10.06 |
| Diluted Average Shares | 9.95 | 9.81 | 9.90 | 0 |
| Basic Average Shares | 9.11 | 8.98 | 9.20 | 0 |
| Diluted NI Availto Com Stockholders | 4.43 | 5.30 | 8.98 | 6.33 |
| Net Income Including Noncontrolling Interests | 4.43 | 5.30 | 8.98 | 6.33 |
| Net Income Continuous Operations | 4.43 | 5.30 | 8.98 | 6.33 |
| Other Income Expense | -0.26 | -1.44 | -0.20 | -2.14 |
| Other Non Operating Income Expenses | 0 | 0 | 0 | -0.05 |
| Special Income Charges | -0.26 | -1.63 | -0.26 | -2.08 |
| Other Special Charges | 0 | 0 | 0 | 0 |
| Restructuring And Mergern Acquisition | 0.26 | 1.63 | 0.26 | 2.08 |
| Gain On Sale Of Security | 0 | 0.19 | 0.05 | -0.02 |
| Net Non Operating Interest Income Expense | 0.12 | -0.74 | -1.30 | -1.76 |
| Total Other Finance Cost | 0 | 0 | 0 | 0 |
| Interest Expense Non Operating | 0 | 1.02 | 1.37 | 1.86 |
| Interest Income Non Operating | 0.12 | 0.29 | 0.07 | 0.10 |
| Depreciation Amortization Depletion Income Statement | 0.07 | 0.09 | 0.11 | 0.42 |
| Depreciation And Amortization In Income Statement | 0.07 | 0.09 | 0.11 | 0.42 |
| Selling And Marketing Expense | 0 | 4.28 | 4.63 | 4.86 |
| General And Administrative Expense | 0 | 7.88 | 9.97 | 14.04 |
| Other Gand A | 0 | 7.88 | 9.97 | 14.04 |
| Operating Revenue | 28.80 | 52.70 | 64.47 | 81.46 |
Consumer Defensive sector peers, ranked by market cap
| Company | Ticker | Market Cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|---|
| FitLife Brands, Inc.this co. | FTLF | $87M | 14.70β discount | 1.99 | 14.5% | 9.60 |
| SkinHealth Systems Inc. | SKIN | $104M | - | 1.68 | -15.6% | 55.16 |
| HF Foods Group Inc. | HFFG | $103M | - | 0.51 | -19.1% | 9.29 |
| Waldencast plc | WALD | $98M | - | 0.20 | -45.9% | -42.73 |
| Solesence, Inc. | SLSN | $92M | 65.00 |
| 5.20 |
| 10.2% |
| 46.52 |
| Zevia PBC | ZVIA | $90M | - | 1.65 | -27.9% | -5.05 |
| Ispire Technology Inc. | ISPR | $76M | - | -9.85 | -6489.3% | -1.88 |
| LifeVantage Corporation | LFVN | $65M | 8.42 | 1.96 | 28.3% | 5.53 |
| Skillsoft Corp. | SKIL | $60M | - | -1.97 | 462.6% | 7.01 |
| Peer Median | - | 36.71 | 1.08 | -17.3% | 6.27 | |